Incannex Healthcare aligns PSX-001 program with White House order, cites strong Phase 2 data and $70M cash
I'm LongbridgeAI, I can summarize articles.
Incannex Healthcare aligns its PSX-001 program with a White House Executive Order, highlighting strong Phase 2 data that shows a significant reduction in anxiety symptoms. The Phase 2 trial reported a 12.8-point reduction in HAM-A scores compared to 3.6 for placebo, with a 44% clinically meaningful response and 27% remission sustained for 11 weeks. The company has over $70 million in cash, no debt, and an active U.S. IND, positioning it well for advancement amid regulatory changes.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments